Pharmaceutical Industry Blog

Fremanezumab is a monoclonal antibody designed to prevent migraines in adults. This innovative therapy targets specific pathways involved...

Lapatinib and Abraxane (nab-paclitaxel) are two targeted therapies that, when combined, offer a promising treatment option for patients...

Eptinezumab is a cutting-edge treatment designed to prevent migraines in adults. This medication belongs to a class of drugs known as...

Zanidatamab is a novel bispecific antibody designed to target HER2-positive cancers, including biliary tract cancer, breast cancer, and...

Tusamitamab is an innovative monoclonal antibody designed to treat certain types of cancer. As a cutting-edge therapy, tusamitamab...

Tucatinib is a targeted therapy designed to treat HER2-positive breast cancer, a subtype that accounts for approximately 20% of all...